'We need to be prepared': FDA will draft guidance to work with vaccine, drug and testing companies on COVID-19 variants

FDA plans to develop guidance to help COVID-19 vaccine, drug and testing manufacturers adapt to emerging variants of the SARS-CoV-2 virus.

      

from USATODAY - News Top Stories https://ift.tt/2O7CPqm